Lagevrio questions, mRNA jab misunderstandings and nasal vaccines coming

Listen to the episode

Description

Going Viral Episode 207

In this episode:

  • Despite a panoramic study suggesting a lower effect, Lagevrio has a useful impact on hospitalisations, deaths and shorter recovery time
  • COVID trials becoming more difficult to run because so many people have either been vaccinated and / or exposed
  • How the Pfizer vaccination’s lack of impact on transmission is not cause for concern and was clearly communicated since its release. The main impact is the reduction of severity, hospitalisations and death, and the data for this hasn’t changed
  • How a nasal vaccination might be coming

 

Host: Dr David Lim, GP and Medical Educator

Total time: 21 mins

Guest: A/Prof Paul Griffin, Infectious Diseases Physician and Clinical Microbiologist
 

Last Updated: 17 Oct, 2022

Further your CPD learning

Based on this educational activity, complete these learning modules to gain additional CPD.

Icon 2

NEXT LIVE Webcast

:
Days
:
Hours
:
Minutes
Seconds
Prof Andrew Sindone

Prof Andrew Sindone

Heart Failure – Demystifying Pharmacological Management for GPs

Dr Rupert Hinds

Dr Rupert Hinds

Iron Deficiency in Children & Young People

Speaker TBA

Speaker TBA

Heart Failure – Assessment and Monitoring in Primary Care

Prof Dave Singh

Prof Dave Singh

COPD Update

Join us for the next free webcast for GPs and healthcare professionals

High quality lectures delivered by leading independent experts

Prof Paul Griffin

expert

Prof Paul Griffin

Infectious Diseases Physician and Clinical Microbiologist; Director of Infectious Diseases, Mater Hospital; Lecturer, University of Queensland;

Recent articles

Share this

You have completed the Educational Activities component of this resource. 

Select ‘Confirm & claim CPD‘ to confirm you have engaged with this resource in its entirety and claim your CPD.

You will be taken to explore further CPD learning available to you.